On March 11, 2022, HCA Healthcare, Inc. filed a definitive proxy statement soliciting proxies and urged the shareholders to vote against a shareholder proposal, requesting the Company provide a report, updated semiannually, disclosing the Company's: 1) policies and procedures for making, with corporate funds or assets, contributions and expenditures (direct or indirect) to (a) participate or intervene in any campaign on behalf of (or in opposition to) any candidate for public office, or (b) influence the general public, or any segment thereof, with respect to an election or referendum and 2) monetary and non-monetary contributions and expenditures (direct and indirect) used in the manner described in section 1 above, including: (a) the identity of the recipient as well as the amount paid to each; and (b) the title(s) of the person(s) in the Company responsible for decision-making, submitted by John Chevedden at the Company's annual shareholders meeting scheduled to be held on April 21, 2022.